Browse hierarchy: [Hematology (HE)](/submissions/HE) → [Subpart A](/submissions/HE/subpart-a%E2%80%94) → [21 CFR 660.30](/submissions/HE/subpart-a%E2%80%94/660.30) → QHT — Reagent Red Blood Cells

# QHT · Reagent Red Blood Cells

_Hematology · 21 CFR 660.30 · Class U_

**Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-a%E2%80%94/QHT

## Overview

- **Product Code:** QHT
- **Device Name:** Reagent Red Blood Cells
- **Regulation:** [21 CFR 660.30](/submissions/HE/subpart-a%E2%80%94/660.30)
- **Device Class:** U
- **Review Panel:** [Hematology](/submissions/HE)

## Identification

The proper name of the product shall be Reagent Red Blood Cells, which shall consist of a preparation of human red blood cells used to detect or identify human blood-group antibodies.

## Recent Cleared Devices (0 of 0)

_No cleared devices on record._

---

**Source:** [https://fda.innolitics.com/submissions/HE/subpart-a%E2%80%94/QHT](https://fda.innolitics.com/submissions/HE/subpart-a%E2%80%94/QHT)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com